Next, we studied whether CCL5 expression in TCs or in ICs was an independent prognostic marker in all MIBC patients or in subgroups of MIBC patients stratified according to tumor stage, lymph node stage, chemotherapy treatment or molecular subtype. Here, CCL5 is linked to neoplasm.